EHS
EHS

FDA Goes Ahead With Approval of Sufentanil Despite Controversy



The FDA’s approval of sufentanil, a highly potent opioid for severe acute pain in adults in certified medically supervised healthcare settings, causes controversy with claims that the vote was rigged.
FDA Approvals

Source link

EHS
Back to top button